重症患者抗菌治疗的经验性决策 - Suppr

Suppr

超能文献

Empirical decision-making for antimicrobial therapy in critically ill patients.

作者信息

Ippolito M, Cortegiani A

机构信息

University of Palermo, Palermo, Italy.

Policlinico Paolo Giaccone, Palermo, Italy.

出版信息

BJA Educ. 2023 Dec;23(12):480-487. doi: 10.1016/j.bjae.2023.09.001. Epub 2023 Oct 19.

DOI:10.1016/j.bjae.2023.09.001

PMID:38009140

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10667614/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8f/10667614/7757721980ae/gr1.jpg

相似文献

Empirical decision-making for antimicrobial therapy in critically ill patients.重症患者抗菌治疗的经验性决策

BJA Educ. 2023 Dec;23(12):480-487. doi: 10.1016/j.bjae.2023.09.001. Epub 2023 Oct 19.

No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.初始经验性碳青霉烯类治疗的危重症患者死亡率无改善，且与更长时间使用相关的多药耐药病原体检出率更高：一项前瞻性队列研究的事后分析。

Microbiol Spectr. 2024 Jul 2;12(7):e0034224. doi: 10.1128/spectrum.00342-24. Epub 2024 Jun 12.

Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials.成人、儿科和新生儿重症监护病房的药物利用情况，重点是全身用抗菌药物。

Anaesthesiol Intensive Ther. 2021;53(1):18-24. doi: 10.5114/ait.2021.103628.

Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient.脓毒症管理中的抗生素管理：为重病患者实现抗生素的平衡使用。

Expert Rev Anti Infect Ther. 2019 Feb;17(2):89-97. doi: 10.1080/14787210.2019.1568239. Epub 2019 Jan 23.

Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial.脓毒症重症患者中β-内酰胺类抗生素标准剂量与双倍剂量对比研究：一项多中心随机对照试验的BULLSEYE研究方案

BMC Infect Dis. 2025 Mar 21;25(1):392. doi: 10.1186/s12879-025-10747-3.

Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU.在 ICU 中治疗脓毒症患者的抗微生物耐药革兰氏阴性菌时，新型抗生素的疗效和适宜性。

Expert Rev Anti Infect Ther. 2022 Apr;20(4):513-531. doi: 10.1080/14787210.2022.1999804. Epub 2021 Dec 8.

Use of selective gut decontamination in critically ill children: PICnIC a pilot RCT and mixed-methods study.使用选择性肠道去污染在危重症儿童中的应用： PICnIC 一项先导 RCT 和混合方法研究。

Health Technol Assess. 2024 Feb;28(8):1-84. doi: 10.3310/HDKV1008.

The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit.重症监护病房中经验性抗菌治疗不足对血流感染患者的影响。

Clin Microbiol Infect. 2003 May;9(5):412-8. doi: 10.1046/j.1469-0691.2003.00656.x.

Antimicrobial resistance and outcome in the critically ill patient: An opinion paper.危重症患者的抗菌药物耐药性和结局：专家意见。

J Crit Care. 2023 Oct;77:154352. doi: 10.1016/j.jcrc.2023.154352. Epub 2023 Jun 9.

Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.严重危重症患者降钙素原指导抗生素治疗无效：一项荟萃分析。

Int J Infect Dis. 2019 Aug;85:158-166. doi: 10.1016/j.ijid.2019.05.034. Epub 2019 Jun 21.

引用本文的文献

Novel therapies and interventions in sepsis and septic shock.脓毒症和脓毒性休克的新型治疗方法与干预措施。

BJA Educ. 2025 May;25(5):206-217. doi: 10.1016/j.bjae.2025.01.003. Epub 2025 Feb 19.

Evaluation of T2 Magnetic Resonance (T2MR) Technology for the Early Detection of ESKAPEc Pathogens in Septic Patients.评估T2磁共振（T2MR）技术用于早期检测脓毒症患者中的ESKAPEc病原体。

Antibiotics (Basel). 2024 Sep 14;13(9):885. doi: 10.3390/antibiotics13090885.

本文引用的文献

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.美国传染病学会2023年抗微生物药物耐药革兰氏阴性菌感染治疗指南

Clin Infect Dis. 2023 Jul 18. doi: 10.1093/cid/ciad428.

Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement.重症监护病房抗菌药物管理原则的基本原理及临床应用：多学科声明

J Anesth Analg Crit Care. 2023 May 1;3(1):11. doi: 10.1186/s44158-023-00095-6.

Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial.连续性与间歇性美罗培南给药在脓毒症危重症患者中的比较：MERCY 随机临床试验。

JAMA. 2023 Jul 11;330(2):141-151. doi: 10.1001/jama.2023.10598.

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.重症监护病房获得性血流感染患者的流行病学和结局：EUROBACT-2 国际队列研究。

Intensive Care Med. 2023 Feb;49(2):178-190. doi: 10.1007/s00134-022-06944-2. Epub 2023 Feb 10.

T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience.脓毒症或脓毒性休克重症患者的T2细菌及T2耐药性检测：一项描述性经验

Antibiotics (Basel). 2022 Dec 15;11(12):1823. doi: 10.3390/antibiotics11121823.

Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies.BioFire 血培养鉴定 2 面板（BCID2）检测血流感染病原体及其相关耐药标志物的性能：系统评价和诊断准确性研究的荟萃分析。

BMC Infect Dis. 2022 Oct 20;22(1):794. doi: 10.1186/s12879-022-07772-x.

Aerosolized polymyxins for ventilator-associated pneumonia caused by extensive drug resistant Gram-negative bacteria: class, dose and manner should remain the trifecta.用于治疗广泛耐药革兰氏阴性菌引起的呼吸机相关性肺炎的雾化多粘菌素：类别、剂量和方式应仍是关键三要素。

Ann Intensive Care. 2022 Oct 17;12(1):97. doi: 10.1186/s13613-022-01068-8.

Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I.重症监护病房患者抗菌药物的组织穿透性：系统评价 - 第一部分

Antibiotics (Basel). 2022 Aug 29;11(9):1164. doi: 10.3390/antibiotics11091164.

Source control in the management of sepsis and septic shock.脓毒症和感染性休克管理中的源头控制

Intensive Care Med. 2022 Dec;48(12):1799-1802. doi: 10.1007/s00134-022-06852-5. Epub 2022 Sep 14.

Healthcare-associated central nervous system infections.医源性中枢神经系统感染

Curr Opin Anaesthesiol. 2022 Oct 1;35(5):549-554. doi: 10.1097/ACO.0000000000001167. Epub 2022 Aug 9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验